Eagle Ridge Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $328K | Hold |
12,365
| – | – | 0.03% | 115 |
|
|
2024
Q3 | $358K | Sell |
12,365
-617
| -5% | -$18K | 0.03% | 113 |
|
|
2024
Q2 | $363K | Sell |
12,982
-4,825
| -27% | -$133K | 0.03% | 112 |
|
|
2024
Q1 | $494K | Buy |
17,807
+1,151
| +7% | +$31.9K | 0.05% | 100 |
|
|
2023
Q4 | $480K | Sell |
16,656
-2,887
| -15% | -$87.3K | 0.05% | 101 |
|
|
2023
Q3 | $648K | Sell |
19,543
-6,365
| -25% | -$225K | 0.07% | 86 |
|
|
2023
Q2 | $950K | Sell |
25,908
-8,716
| -25% | -$339K | 0.1% | 73 |
|
|
2023
Q1 | $1.41M | Buy |
34,624
+3,831
| +12% | +$165K | 0.16% | 63 |
|
|
2022
Q4 | $1.58M | Sell |
30,793
-361
| -1% | -$17.3K | 0.18% | 65 |
|
|
2022
Q3 | $1.36M | Buy |
31,154
+71
| +0.2% | +$3.45K | 0.17% | 66 |
|
|
2022
Q2 | $1.63M | Hold |
31,083
| – | – | 0.2% | 66 |
|
|
2022
Q1 | $1.61M | Buy |
31,083
+2,300
| +8% | +$119K | 0.17% | 70 |
|
|
2021
Q4 | $1.7M | Hold |
28,783
| – | – | 0.18% | 69 |
|
|
2021
Q3 | $1.24M | Buy |
28,783
+2,982
| +12% | +$132K | 0.14% | 73 |
|
|
2021
Q2 | $1.01M | Hold |
25,801
| – | – | 0.12% | 74 |
|
|
2021
Q1 | $935K | Sell |
25,801
-180
| -0.7% | -$6.39K | 0.11% | 75 |
|
|
2020
Q4 | $956K | Buy |
25,981
+2,475
| +11% | +$90.8K | 0.12% | 76 |
|
|
2020
Q3 | $818K | Buy |
23,506
+2,750
| +13% | +$96.4K | 0.11% | 78 |
|
|
2020
Q2 | $644K | Hold |
20,756
| – | – | 0.1% | 82 |
|
|
2020
Q1 | $643K | Buy |
20,756
+307
| +2% | +$10.5K | 0.11% | 75 |
|
|
2019
Q4 | $760K | Hold |
20,449
| – | – | 0.1% | 83 |
|
|
2019
Q3 | $697K | Hold |
20,449
| – | – | 0.1% | 84 |
|
|
2019
Q2 | $840K | Hold |
20,449
| – | – | 0.12% | 80 |
|
|
2019
Q1 | $824K | Sell |
20,449
-170
| -0.8% | -$6.81K | 0.12% | 82 |
|
|
2018
Q4 | $854K | Hold |
20,619
| – | – | 0.15% | 80 |
|
|
2018
Q3 | $862K | Hold |
20,619
| – | – | 0.12% | 86 |
|
|
2018
Q2 | $710K | Sell |
20,619
-3,181
| -13% | -$109K | 0.11% | 91 |
|
|
2018
Q1 | $801K | Buy |
23,800
+2,687
| +13% | +$92.4K | 0.12% | 86 |
|
|
2017
Q4 | $726K | Hold |
21,113
| – | – | 0.11% | 95 |
|
|
2017
Q3 | $715K | Sell |
21,113
-80
| -0.4% | -$2.57K | 0.12% | 92 |
|
|
2017
Q2 | $225K | Buy |
21,193
+14,484
| +216% | +$457K | 0.04% | 122 |
|
|
2017
Q1 | $218K | Sell |
6,709
-3,777
| -36% | -$119K | 0.04% | 129 |
|
|
2016
Q4 | $323K | Sell |
10,486
-1,133
| -10% | -$34.6K | 0.07% | 107 |
|
|
2016
Q3 | $373K | Sell |
11,619
-624
| -5% | -$20.9K | 0.08% | 95 |
|
|
2016
Q2 | $409K | Buy |
12,243
+1,581
| +15% | +$50.5K | 0.09% | 94 |
|
|
2016
Q1 | $300K | Sell |
10,662
-387
| -4% | -$11.1K | 0.07% | 104 |
|
|
2015
Q4 | $338K | Buy |
11,049
+880
| +9% | +$27.7K | 0.08% | 98 |
|
|
2015
Q3 | $303K | Buy |
10,169
+2,291
| +29% | +$73.5K | 0.08% | 95 |
|
|
2015
Q2 | $251K | Hold |
7,878
| – | – | 0.11% | 50 |
|
|
2015
Q1 | $260K | Sell |
7,878
-1,054
| -12% | -$33.5K | 0.12% | 51 |
|
|
2014
Q4 | $264K | Hold |
8,932
| – | – | 0.12% | 49 |
|
|
2014
Q3 | $251K | Hold |
8,932
| – | – | 0.12% | 50 |
|
|
2014
Q2 | $252K | Sell |
8,932
-2,318
| -21% | -$66.1K | 0.12% | 53 |
|
|
2014
Q1 | $343K | Buy |
+11,250
| New | +$335K | 0.17% | 49 |
|
Other funds holding PFE
Eagle Ridge Investment Management's PFE Position: Q4 2024 in Review
Eagle Ridge Investment Management held its Pfizer (PFE) position steady in Q4 2024 at 12,365 shares worth $328K. The position accounts for 0.03% of the portfolio, ranked #115.
Eagle Ridge Investment Management first reported a position in PFE in Q1 2014 and has held it in 44 quarters since. The position peaked at $1.7M in Q4 2021. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.
- Eagle Ridge Investment Management held 12,365 shares of Pfizer worth $328K as of Q4 2024.
- Eagle Ridge Investment Management left its Pfizer share count unchanged in Q4 2024.
- Pfizer made up 0.03% of Eagle Ridge Investment Management's portfolio in Q4 2024, its #115 holding.
- Eagle Ridge Investment Management first reported a position in Pfizer in Q1 2014 and has held it in 44 quarters since.
- Eagle Ridge Investment Management's Pfizer position peaked at $1.7M in Q4 2021.
- 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.
Based on Eagle Ridge Investment Management's 13F filing for Q4 2024, filed 27 Jan 2025.